Shire is taking aim at Johnson & Johnson’s ($JNJ) Concerta. The Irish drugmaker is sponsoring two head-to-head trials pitting its ADHD drug Vyvanse against the J&J product as a treatment for adolescents with the disorder. But it’s not just J&J’s branded product in Shire’s sights. Generic versions of Concerta are already on the market, and ...
Get this: Only about 1 in 20 law firms have their websites professionally managed. The other 95% have a site built, then decide they’ll somehow make it searchable but they have no clue what they’re doing, so their big investment starts collecting cyber dust like a box of brochures on a shelf. See: